News Center

Home page

Peak Report

News reports

Jinxi plant environmental protection facilities through the completion of acceptance

Release time:

2020-07-30

News from our newspaper 11# April , Jianfeng Pharmaceutical Jinxi Pharmaceutical Factory successfully obtained the approval from Zhejiang Environmental Protection Department that the environmental protection facilities of the project passed the completion acceptance, and a key work of Jianfeng Pharmaceutical 2016 came to an end.

Peak Pharmaceutical Co., Ltd. has an annual output of 35 tons of cephalosporins, antitumor drugs and other raw material production lines and various preparation production lines. The technical renovation project started construction in Jinxi Development Zone in 2012 , 10 , and was basically completed in 2015 , 9 . The construction of the project strictly abides by the "three simultaneous" system of environmental protection, conscientiously implements the requirements in the environmental impact assessment report and its approval documents, and the investment in environmental protection facilities amounts to 1934 yuan. The plant has basically realized the separation of clean and sewage. A new wastewater treatment system with a daily treatment capacity of 700 cubic meters and a "physicochemical biochemical" treatment process has been built, and an online monitoring device connected with the environmental protection department has been installed. All kinds of production wastewater, public works wastewater and domestic sewage will be collected after reaching the standard by the wastewater station and sent to Jinxi Sewage Treatment Plant for centralized treatment; there is a RTO regenerative incineration device with ,000 cubic meters per hour and a ,4,000 cubic meters per hour centralized treatment device for chlorine-containing organic waste gas. All kinds of waste gas are collected and treated and discharged. 2015 10# In July, with the approval of Jinhua Economic and Technological Development Zone Branch of Jinhua Environmental Protection Bureau, Jinxi Project was put into trial production.

After more than half a year of operation, in early

2016 7 , Zhejiang Environmental Monitoring Center Station carried out completion acceptance monitoring of environmental protection treatment facilities such as waste water and waste gas in Jinxi Pharmaceutical Factory, and issued a completion acceptance monitoring report of environmental protection facilities at the end of 8 , believing that the completion acceptance conditions of environmental protection facilities for construction projects were basically met. In order to further improve the waste gas treatment work, the pharmaceutical company also commissioned professional institutions to carry out waste gas leakage, detection and repair, and carried out scientific detection on the unorganized emission of VOCs (volatile organic compounds) at each leakage point, repaired the trace leakage point, and finally formed a detection report.

February 13 , relevant departments of Zhejiang provincial environmental protection department presided over an on-site meeting for the completion and acceptance of environmental protection facilities for Jinxi project. The leader of the acceptance team is He Wei, the Construction Project Management Office of the Provincial Environmental Protection Department. The members include leaders of Jinhua Environmental Protection Bureau and other units and provincial environmental protection experts, as well as professional institutions such as Zhejiang Environmental Monitoring Center Station and Zhejiang Huanke Environmental Consulting Co., Ltd. Representative. At the acceptance meeting, Shen Quan, director of Jinxi factory, introduced the main construction contents and operation of environmental protection facilities of Jinxi project. The provincial monitoring station explained the monitoring situation of the project, and Hangzhou Huanliang Environmental Protection Technology Co., Ltd. explained the environmental supervision of the project in detail. The acceptance team also went to the site to inspect the actual operation and use of waste water and waste gas treatment facilities, RTO incineration device, online monitoring system, hazardous waste warehouse, etc., and checked the production status of bulk drug workshop, etc. After careful deliberation, the acceptance team agreed that the project has basically implemented the main environmental protection measures proposed in the EIA and approval, and agreed in principle that the supporting environmental protection facilities have passed the completion acceptance.

1 , Zhejiang Provincial Environmental Protection Department issued an approval document for Jinxi Project to pass the environmental protection completion acceptance, and made requirements for environmental protection precautions after the project is in operation. (Zhu Xiaojing)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页